Saturday, November 27, 2021
Home Search

Zydus Cadila - search results

If you're not happy with the results, please do another search
USFDA

USFDA gives final nod to Zydus Cadila for Glycopyrrolate Injection

Ahmedabad, India: Global pharmaceutical company Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market its glycopyrrolate injection,...
USFDA

USFDA gives tentative nod to Zydus Cadila for Adapalene and Benzoyl Peroxide Gel

Zydus Cadila has received tentative approval from the US Food and Drugs Administration (USFDA) to market Adapalene and Benzoyl Peroxide Gel 0.3%/2.5%....

Here are some facts about Zydus Cadila’s Vaccine ZyCoV-D

Here are some facts about Zydus Cadila's Vaccine ZyCoV-D A day after getting the emergency use authorisation (EUA) in...
Medicine Injection

India’s cheapest remdesivir launched by Zydus Cadila: Rs 2,800 per vial

BENGALURU: Zydus Cadila on Thursday launched the cheapest generic version of Gilead Sciences' antiviral drug remdesivir in India to treat COVID-19 following reports of shortages at hospitals in...
USFDA

Zydus Cadila gets USFDA nod to market generic Cancer drug in US

Drug firm Zydus Cadila on Saturday said it has received approval from the US health regulator to market Decitabine injection, used to treat certain types of...
Zudus

Zydus Cadila’s vaccine to be administered to adults only as of now

New Delhi: Zydus Cadila’s C-19 vaccine, ZyCov-D, which has been cleared by India’s drug regulator for those aged 12 years and above, will...
Zudus

Zydus Cadila to reduce its Vaccine price

New Delhi: Zydus Cadila has agreed to bring down the price of its C-19 vaccine to Rs 265 a dose following persistent negotiations...
Zudus

Zydus Cadila proposes Rs 1900 for three dose C-19 vaccine

With talks underway between the central government and Zydus Cadila over the pricing of the C-19 vaccine ZyCov-D, the pharma company is...
USFDA

Zydus Cadila gets USFDA nod for drug to treat Psoriasis

NEW DELHI: Drug firm Zydus Cadila said it has received approval from the US health regulator to market Apremilast tablets, used to...
USFDA

Zydus Cadila gets USFDA nod for Antidepressant drug

Zydus Cadila has received final approval from the USFDA to market Vortioxetine Tablets in the strengths of 5 mg, 10 mg, 20...
USFDA

Zydus Cadila gets tentative nod from USFDA for Brexpiprazole tablets

Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Brexpiprazole tablets in the strength of...
USFDA

Zydus Cadila gets USFDA nod for Tofacitinib ER Tablets

Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market tofacitinib extended release tablets, 11 mg...
USFDA

Zydus Cadila gets USFDA nod for Mesalamine ER capsules

Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market mesalamine extended-release capsules in the strength...
USFDA

Zydus Cadila gets final nod from USFDA for Fulvestrant injection

Zydus Cadila has received the final approval from the US Food and Drug Administration (USFDA) to market Fulvestrant injection, 250 mg/5 mL...
Medicine Tablet

Zydus Cadila gets USFDA nod for Ibrutinib tablets

Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Ibrutinib tablets, in the strengths of...
USFDA

Zydus Cadila gets USFDA nod for drug to treat HIV infection

Zydus Cadila has received final approval from US Food and Drug Administration (USFDA) to market emtricitabine and tenofovir disoproxil fumarate tablets, 100...
Zudus

Zydus Cadila gets tentative nod from USFDA for Pemetrexed for Injection

Zydus Cadila has received tentative approval from the USFDA to market Pemetrexed for Injection in the strengths of 100mg/vial, 500 mg/vial, and...
USFDA

Zydus Cadila gets tentative nod from USFDA for Fingolimod Capsules

Zydus Cadila has received tentative approval from the United States US (USFDA) to market Fingolimod capsules in the strength of 0.25 mg...

Zydus Cadila gets tentative USFDA nod for Epilepsy drug

Zydus Cadila has received tentative approval from the USFDA to market Brivaracetam Tablets, in the strengths of 10 mg, 25 mg, 50...
Laboratory

Zydus Cadila gets nod for Clinical Trials of Antibodies cocktail

New Delhi: The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of C-19 has been given...
USFDA

Zydus Cadila gets tentative USFDA nod for Osimertinib Tablets

Zydus Cadila has received tentative approval from the USFDA to market Osimertinib Tablets in the strengths of 40 mg and 80 mg...
Injection vaccine Medicine

Zydus Cadila plans to test its C-19 vaccine for 5-12 age group

After covering adults and children aged between 12 and 18 years under the ongoing clinical trials of its C-19 vaccine ZyKov-D, Zydus Cadila now plans to test its plasmid...
USFDA

Zydus Cadila gets USFDA nod for Fluphenazine HCL Tablets

Zydus Cadila has received final approval from the USFDA to market Fluphenazine Hydrochloride Tablets in the strengths of 1 mg, 2.5 mg,...

Zydus Cadila launches drug for Breast cancer treatment

Zydus Cadila, a global innovation driven healthcare company, launched trastuzumab emtansine, the first antibody drug conjugate (ADC) biosimilar and a highly effective...

Latest posts

High Court restrains publishing Ads in a dispute on Chyawanprash

The Calcutta High Court has issued an interim injunction restraining Shree Baidyanath Ayurved Bhawan Pvt Ltd from issuing certain print and video...

Authors

58 POSTS0 COMMENTS
30 POSTS0 COMMENTS
20 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
9 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS